Year archive

Lonza Group AG — 2021 filings

All 8 regulatory filings released by Lonza Group AG (LONN) in 2021, sourced directly from the official regulator.

8 Filings

2021 Period

2021 filings (8)

Filing	Released	Lang
Capital Markets Day 2021: Lonza to Capture Market Demand and Ensure Sustainable Value Creation Through Long-Term Growth Earnings Release H1 2021	2021-10-12	English
Philippe Deecke appointed as Chief Financial Officer of Lonza Group Board/Management Information	2021-08-26	English
Lonza Reports Strong Momentum in H1 2021, with 14.7% CER Sales Growth and 33.3% CORE EBITDA Margin Earnings Release H1 2021	2021-07-23	English
Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody Commercial Supply Regulatory Filings	2021-07-16	English
Lonza Completes Divestment of Specialty Ingredients Business Delisting Announcement	2021-07-02	English
Lonza Publishes Restated Financials for 2020 Earnings Release FY 2020	2021-06-29	English
Lonza and Moderna Announce Further Collaboration For Drug Substance Manufacturing of COVID-19 Vaccine Moderna in the Netherlands M&A Activity	2021-06-02	English
Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US) Regulatory Filings	2021-05-06	English